Saline (0.9%, sterile, for infusion)
2025-I2M-C&T-B-090B
Phase 3 small_molecule active
Quick answer
Saline (0.9%, sterile, for infusion) for Pneumocystis Jiroveci Pneumonia is a Phase 3 program (small_molecule) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- China SXT Pharmaceuticals
- Indication
- Pneumocystis Jiroveci Pneumonia
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active